ATE514415T1 - Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide - Google Patents

Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide

Info

Publication number
ATE514415T1
ATE514415T1 AT07747448T AT07747448T ATE514415T1 AT E514415 T1 ATE514415 T1 AT E514415T1 AT 07747448 T AT07747448 T AT 07747448T AT 07747448 T AT07747448 T AT 07747448T AT E514415 T1 ATE514415 T1 AT E514415T1
Authority
AT
Austria
Prior art keywords
heartburn
reflux disease
gerd
gastroesophageal reflux
reducing symptoms
Prior art date
Application number
AT07747448T
Other languages
English (en)
Inventor
Maria Anna Verbruggen
Calvin T Kelly
Blaine G Sudom
Original Assignee
Frutarom Netherlands B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frutarom Netherlands B V filed Critical Frutarom Netherlands B V
Application granted granted Critical
Publication of ATE514415T1 publication Critical patent/ATE514415T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
AT07747448T 2006-05-16 2007-05-16 Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide ATE514415T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06076056A EP1859786A1 (de) 2006-05-16 2006-05-16 Methode zu vermindern die Symptome von Sodbrennen und Gastro-speiseröhren Rücklaufkrankheit durch spezifischen polysaccharides
US80631306P 2006-06-30 2006-06-30
PCT/NL2007/050224 WO2007133082A1 (en) 2006-05-16 2007-05-16 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides

Publications (1)

Publication Number Publication Date
ATE514415T1 true ATE514415T1 (de) 2011-07-15

Family

ID=37806824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07747448T ATE514415T1 (de) 2006-05-16 2007-05-16 Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide

Country Status (9)

Country Link
US (2) US20090252792A1 (de)
EP (2) EP1859786A1 (de)
JP (1) JP2009537512A (de)
KR (1) KR20090048393A (de)
AT (1) ATE514415T1 (de)
AU (1) AU2007250624B2 (de)
RU (1) RU2432167C2 (de)
TW (1) TWI402074B (de)
WO (1) WO2007133082A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
US10463623B2 (en) 2008-09-22 2019-11-05 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract
HRP20150100T1 (hr) 2010-04-26 2015-05-08 Angel Manuel Gago De Santos Pripravci za simptomatsko olakšavanje boli u želucu ili gastroezofagealnog refluksa
ITRM20120041A1 (it) * 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
ITRM20120084A1 (it) * 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
AU2013235266B2 (en) 2012-03-20 2017-10-19 Particle Dynamics International, Llc Gelling agent-based dosage form
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
IT201700091733A1 (it) * 2017-08-08 2019-02-08 Neilos S R L Composizione per somministrazione orale per uso nel trattamento terapeutico o preventivo dei disturbi o malattia da reflusso gastroesofageo
JP2019064980A (ja) * 2017-10-03 2019-04-25 小林製薬株式会社 逆流性食道炎改善剤
MX2021000704A (es) 2018-07-23 2021-05-12 Nutragenom Llc Composicion y metodos para generar y mantener hidrogeno molecular (h2) en sistemas acuosos.
CN111227156A (zh) * 2020-01-20 2020-06-05 陕西科技大学 一种抑制反酸的固体饮料及其制备方法
WO2022240224A1 (ko) * 2021-05-14 2022-11-17 한국식품연구원 젤란검을 유효성분으로 하는 장내 균총 개선용 조성물 및 이를 포함하는 대사성 질환 개선, 예방 또는 치료용 조성물
TWI777673B (zh) * 2021-07-16 2022-09-11 陳昭誠 由β-1-4-葡聚醣形成之纖維於製備用於治療或預防胃食道逆流之組成物之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3152319C2 (de) * 1980-09-03 1986-05-07 Kyosei Pharmaceutical Co., Ltd., Hokkaido Verwendung einer Lösung eines Salzes der Alginsäure zur Behandlung von Strahlenschäden und Ulcera
IL108583A (en) * 1994-02-07 1997-06-10 Yissum Res Dev Co Galactomannan emulsions and comestible products containing the same
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
CA2206157C (en) * 1997-05-26 2000-06-13 Cheng, Peter Method of extraction of commercially valuable fractions of fenugreek
GB9910212D0 (en) * 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB0005743D0 (en) * 2000-03-10 2000-05-03 Reckitt & Colmann Prod Ltd Pharmaceutical compositions including alginates
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
EP1618149B1 (de) * 2003-04-25 2007-01-17 Reckitt Benckiser Healthcare (UK) Limited Verdickbare zusammensetzungen
DK1638586T3 (da) * 2003-05-14 2008-06-23 Indus Biotech Pvt Ltd Synergistisk sammensætning til behandling af diabetes mellitus

Also Published As

Publication number Publication date
RU2008149527A (ru) 2010-06-27
TWI402074B (zh) 2013-07-21
EP2026763A1 (de) 2009-02-25
WO2007133082A1 (en) 2007-11-22
AU2007250624A1 (en) 2007-11-22
JP2009537512A (ja) 2009-10-29
TW200812596A (en) 2008-03-16
EP2026763B1 (de) 2011-06-29
RU2432167C2 (ru) 2011-10-27
KR20090048393A (ko) 2009-05-13
US20120231078A1 (en) 2012-09-13
AU2007250624B2 (en) 2012-09-20
EP1859786A1 (de) 2007-11-28
US20090252792A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
ATE514415T1 (de) Verfahren zur reduzierung der symptome von sodbrennen und gastroösophagealer reflux- krankheit (gerd) durch spezifische polysaccharide
ATE547099T1 (de) Flüssige zusammensetzungen aus calciumacetat
NO20073753L (no) En sammensetning og fremgangsmate for fremstilling av et proppemiddel
BRPI0910182A2 (pt) composto de fórmula (i), composição farmacêutica, método de tratamento de um distúrbio e uso de um composto"
ATE541928T1 (de) Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen
DE602006019619D1 (de) Verfahren zur verbesserung der gewinnung von wässrigen fluiden aus unterirdischen formationen
DE602006007032D1 (de) Bitumenzusammensetzung
ATE509622T1 (de) Amphetamin-ornithine konjugate sowie herstellungs-und verwendungsverfahren
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
NO20084923L (no) N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer
ATE458535T1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
ECSP067067A (es) Derivados de quinazolinona útiles como antagonistas vanilloides
DK1979474T3 (da) Aviær telomerase revers transkriptase
WO2007030361A3 (en) Benzimidazole thiophene compounds as plk inhibitors
WO2008063781A3 (en) Chemical compounds as cannabinoid receptor ligands
DE502007004582D1 (de) Verwendung von ölhaltigen weichwachsen als hydrophobierungsmittel in holzwerkstoffen, holzwerkstoffe so hergestellt und verfahren zur einbringung von weichwachsen in die holzwerkstoffe
DOP2011000329A (es) Preparacion de solido
ATE512969T1 (de) Benzimidazolderivate als selektive säurepumpenhemmer
EP1986849A4 (de) Waschechte schwelen unterdrückende zusammensetzungen
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EA200800889A1 (ru) Гексагидроциклооктилпиразольные каннабиноидные модуляторы
MEP10209A (en) Stable emulsion composition
DE502007000436D1 (de) Neue Verwendungen von 4-Methyl-5-hydroxy-hexansäurelacton
PL1922128T3 (pl) Element do zmniejszania zawartości drobnego pyłu w powietrzu, za pomocą mchów i/lub porostów

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties